Agenus | AGEN - Loan Capital


Agenus reported $169.66M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Agenus USD 169.66M 146.06M Dec/2025
Amgen USD 51.89B 1.88B Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
CSL USD 10.42B 273M Dec/2025
Eli Lilly USD 39.37B 1.5B Mar/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
GlaxoSmithKline GBP 14.01B 696M Mar/2026
Glaxosmithkline GBP 19.82B 203.13M Dec/2025
Incyte USD 29.41M 785K Mar/2026
Intrexon USD 0 198.67M Jun/2024
J&J USD 37.53B 1.91B Mar/2026
Jiangsu Hengrui CNY 37.1M 6.2M Mar/2026
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025
MacroGenics USD 70M 256K Dec/2025
Merck EUR 10.8B 72M Mar/2026
Merck USD 46.67B 77M Mar/2026
Northwest Biotherapeutics USD 31.8M 11.49M Sep/2025
Novartis USD 37.45B 7.86B Mar/2026
Novavax USD 246.3M 200K Dec/2025
Pfizer USD 60.57B 1.08B Mar/2026
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Rigel Pharmaceuticals USD 0 0 Sep/2024
Sangamo BioSciences USD 0 0 Jun/2022
Veracyte USD 0 0 Mar/2025